SAN ANTONIO BREAST CANCER SYMPOSIUM
December 6-10, 2022
Seven important Presentations from the SABCS 2023 Press Briefings
- Tucatinib Plus Trastuzumab Emtansine May Benefit Patients With Advanced or Metastatic HER2-positive Breast Cancer
- Neoadjuvant Chemotherapy May Help Some Breast Cancer Patients Skip Regional Nodal Irradiation
- Younger Postmenopausal Patients With Early-stage Breast Cancer May Be Able to Safely Omit Adjuvant Radiotherapy
- Exercise May Boost Quality of Life for Patients With Metastatic Breast Cancer
- Patients with HR-positive Breast Cancer May Use Fertility Preservation and Assisted Reproductive Technologies Without Increased Risk of Recurrence
- Skipping Adjuvant Radiotherapy May Not Impact Risk of Recurrence or Progression in Patients with Low-risk DCIS
- Some Breast Cancer Survivors May Safely De-escalate Mammography Three Years After Surgery
- Potentially Targetable Fusion RNAs May Be More Common in Metastatic Breast Cancer Than Previously Realized
- KATHERINE final IDFS and updated OS analysis
- INAVO120 primary analysis
Tucatinib Plus Trastuzumab Emtansine May Benefit Patients With Advanced or Metastatic HER2-positive Breast Cancer
GS01-10
HER2CLIMB-02: Randomized, Double-Blind Phase 3 Trial of Tucatinib and Trastuzumab
Emtansine for Previously Treated HER2-Positive Metastatic Breast Cance
More INFO about Study
Recorded @ SABCS 2023, December 6
SLIDES Courtesy [Presenting Author: Sara Hurvitz, MD, FACP]
Neoadjuvant Chemotherapy May Help Some Breast Cancer Patients Skip Regional Nodal Irradiation
GS02-07
Loco-Regional Irradiation in Patients with Biopsy-proven Axillary Node Involvement at
Presentation Who Become Pathologically Node-negative After Neoadjuvant Chemotherapy:
Primary Outcomes of NRG Oncology/NSABP B-51/RTOG 130
More INFO about Study
Recorded @ SABCS 2023, December 6
SLIDES Courtesy Presenting Author: Eleftherios (Terry) Mamounas, MD, MP
Younger Postmenopausal Patients With Early-stage Breast Cancer May Be Able to Safely Omit Adjuvant Radiotherapy
GS02-08
Five-year outcomes of the IDEA trial of endocrine therapy without radiotherapy after breast-
conserving surgery for postmenopausal patients age 50-69 with genomically-selected favorable
Stage I breast cancer
More INFO about Study
Recorded @ SABCS 2023, December 7
Exercise May Boost Quality of Life for Patients With Metastatic Breast Cancer
GS02-10
Effects of a structured and individualized exercise program on fatigue and health-related quality
of life in patients with metastatic breast cancer: the multinational randomized controlled
PREFERABLE-EFFECT study
More INFO about Study
Recorded @ SABCS 2023, December 7
SLIDES Courtesy [Presenting Author: Anne M. May, PhD]
Patients with HR-positive Breast Cancer May Use Fertility Preservation and Assisted Reproductive Technologies Without Increased Risk of Recurrence
GS02-11
Fertility preservation and assisted reproductive technologies (ART) in breast cancer (BC) patients
(pts) interrupting endocrine therapy (ET) to attempt pregnancy
More INFO about Study
Recorded @ SABCS 2023, December 7
SLIDES Courtesy [Presenting Author: Hatem A. Azim, Jr., MD, PhD]
Skipping Adjuvant Radiotherapy May Not Impact Risk of Recurrence or Progression in Patients with Low-risk DCIS
GS03-01
Magnetic Resonance Imaging and a 12-Gene Expression Assay to Optimize Local Therapy for
Ductal Carcinoma In Situ: 5-year clinical outcomes of E411
More INFO about Study
Recorded @ SABCS 2023, December 8
SLIDES Courtesy [Presenting Author: Seema Khan, MD]
Some Breast Cancer Survivors May Safely De-escalate Mammography Three Years After Surgery
GS03-02
Mammographic surveillance in early breast cancer patients aged 50 years or over: results of the
Mammo-50 non-inferiority trial of annual versus less frequent mammograph
More INFO about Study
Recorded @ SABCS 2023, December 8
SLIDES Courtesy [Presenting Author: Janet A. Dunn, PhD]
Potentially Targetable Fusion RNAs May Be More Common in Metastatic Breast Cancer Than Previously Realized
GS03-09
Characterization and proposed therapeutic exploitation of fusion RNAs in metastatic breast
cancers
More INFO about Study
Recorded @ SABCS 2023, December 8
SLIDES Courtesy [Presenting Author: Nolan Priedigkeit, MD, PhD]
KATHERINE final IDFS and updated OS analysis
Recorded @ SABCS 2023, December 8
SLIDES Courtesy [Presenting Author: Prof. Dr. Sibylle Loibl ]
INAVO120 primary analysis
Recorded @ SABCS 2023, December 8